Dr. Bruce Turner, the chief executive of Xanadu Bio, a company developing Yale University?s COVID-19 nasal vaccine, in New Haven, Conn., June 8, 2023. A $5 billion federal program aims to make better COVID vaccines, but drugmakers are confused by mur